Market Need

The global medical robotics market is is projected to reach USD 16.74 billion by 2023 from an estimated USD 6.46 billion in 2018, at a CAGR of 21.0%, according to a report recently published by MarketsandMarkets™. The key driving factor for the growth of this market is increasing demand for more accurate surgeries to leave no room for human errors and ensure precision.

XACT™ technology is unique in its ability to accurately and repeatedly deliver needles/tools to desired targets through soft tissue with a proven accuracy of less than 1.5mm. XACT™ can apply to a wide range of applications, procedures and target organs using different imaging systems within the image guided and robot-assisted surgery market.

The first generation of the XACT™ System, currently available to patients in two active Clinical Centers of Excellence, is used to perform ablations, biopsies and other interventional procedures performed under image guidance by interventional radiologists.

The XACT™ system brings many benefits to the current standard of care including:

  • Lessen the exposure of interventional radiologists and patients to large radiation doses
  • Easily target and reach small lesions
  • Performance of complex angulation 3D needle trajectories
  • Ongoing path correction to maintain planned trajectory without needle re-insertion/s
  • Active compensation for target movement resulting from breathing or patient movement
  • Consistent and predictable procedure duration
  • Significant decrease in the learning curve for interventional radiologists

The market is in need of a safe, accurate, and predictable method for performing interventional image-guided procedures, which will allow more interventional radiologists to safely and effectively treat more patients in need.

Need more info?
Send us a message
© XACT Robotics™ 2019. All Rights Reserved. | Website by Volle'